Pyoderma gangrenosum and concomitant hidradenitis suppurativa - Rapid response to canakinumab (anti-IL-1β)

European Journal of Dermatology

Volumn 23, Issue 3, 2013, Pages 408-410

  Jaeger, Teresa ^a   Andres, Christian ^a   Grosber, Martine ^a   Zirbs, Michael ^a   Hein, Rüdiger ^a   Ring, Johannes ^a   Traidl Hoffmann, Claudia ^a  

^a TECHNICAL UNIVERSITY OF MUNICH   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; CANAKINUMAB; STEROID; TACROLIMUS; MONOCLONAL ANTIBODY;

ADULT; CASE REPORT; CAUCASIAN; COMORBIDITY; DISEASE DURATION; DRUG EFFICACY; DRUG RESPONSE; ERYTHEMA; FOLLICULITIS; HUMAN; HUMAN TISSUE; LETTER; MALE; NEUTROPHIL COUNT; PYODERMA GANGRENOSUM; REMISSION; SKIN BIOPSY; SKIN ULCER; SUPPURATIVE HIDRADENITIS; TREATMENT DURATION; ULCER HEALING; COMPLICATION; HIDRADENITIS SUPPURATIVA; TIME;

ADULT; ANTIBODIES, MONOCLONAL; HIDRADENITIS SUPPURATIVA; HUMANS; MALE; PYODERMA GANGRENOSUM; REMISSION INDUCTION; TIME FACTORS;

EID: 84880594003     PISSN: 11671122     EISSN: 19524013     Source Type: Journal    
DOI: 10.1684/ejd.2013.2018     Document Type: Letter

References (10)

1. Al Ghazal P, Körber A, Klode J, Dissemond J. Investigation of new co-factors in 49 patients with pyoderma gangrenosum. J Dtsch Dermatol Ges 2011; 10: 251-7.
2. Jemec GB, Hansen U. Histology of hidradenitis suppurativa. J Am Acad Dermatol 1996; 34: 994-9.
3. Miller J, Yentzer BA, Clark A, Jorizzo JL, Feldman SR. Pyoderma gangrenosum: a review and update on new therapies. J Am Acad Dermatol 2010; 62: 646-54.
4. Guenova E, Teske A, Fehrenbacher B, et al. Interleukin 23 Expression in Pyoderma Gangrenosum and Targeted Therapy With Ustekinumab. Arch Dermatol 2011; 147: 1203-5.
5. Brenner M, Ruzicka T, Plewig G, Thomas P, Herzer P. Targeted treatment of pyoderma gangrenosum in PAPA (pyogenic arthritis, pyoderma gangrenosum and acne) syndrome with the recombinant human interleukin-1 receptor antagonist anakinra. Br J Dermatol 2009; 161: 1199-201.
6. Löhrer R, Eming R, Wolfrum N, Krieg T, Eming SA. Autoinflammatory diseases as cause of wound healing defects. Hautarzt 2011; 62: 524-33.
7. Goldbach-Mansky R, Kastner DL. Autoinflammation: the prominent role of IL-1 in monogenic autoinflammatory diseases and implications for common illnesses. J Allergy Clin Immunol 2009 Dec; 124: 1141-9.
8. Hsiao JL, Antaya RJ, Berger T, Maurer T, Shinkai K, Leslie KS. Hidradenitis suppurativa and concomitant pyoderma gangrenosum: a case series and literature review. Arch Dermatol 2010 Nov; 146: 1265-70.
9. Braun-Falco M, Kovnerystyy O, Lohse P, Ruzicka T. Pyoderma gangrenosum, acne, and suppurative hidradenitis (PASH)-a new autoinflammatory syndrome distinct from PAPA syndrome. J Am Acad Dermatol 2011; 66: 409-15.
10. Hoffman HM. Therapy of autoinflammatory syndromes. J Allergy Clin Immunol 2009; 124: 1129-38.